ProCE Banner Activity

PARP Inhibitors in Advanced Prostate Cancer: Overcoming Global Challenges in Testing and Treatment


Download these slides on the use of PARP inhibitors for patients with advanced prostate cancer, including biomarker testing recommendations, therapy options, and current guideline recommendations.

Released: May 14, 2024

Expiration: May 13, 2025



Karim Fizazi

Karim Fizazi, MD, PhD

Full Professor
Cancer Medicine
Gustave Roussy
Villejuif, France

Joaquin Mateo

Joaquin Mateo, MD, PhD

Medical Oncology Department
Vall d’Hebron University Hospital
Group Leader
Vall d’Hebron Institute of Oncology
Barcelona, Spain

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Pfizer Inc.

Pfizer Inc.